The Institut Cochin
Currently 38 teams, in 3 scientific departments, are actively working in basic as well as translational research domains, in close partnership with on-site clinical departments. Metabolic, infectious and inflammatory diseases, reproduction, development and cancer constitute the major research axes. State-of-the-art core facilities (imaging, histology, flow cytometry, ‘omics’ technologies, creation of murine models, etc..) are a major asset within the Institute and also provide a support hub for many other public and private research teams. The Institut Cochin has a proactive policy for technology transfer and socio-economic valorisation. In addition, the management board of the Institute is backed by efficient administrative, financial and technical support services, which provide expertise and advice to research teams and core facilities.
The director will be
an internationally recognized scientist. He/she will define an ambitious scientific strategy for the Institut Cochin, both at national and international levels; he/she will play a major management role and will make all decisions, in concertation with the management board of the Institute, regarding expenses based on the financial and human resources that the Institute receives from its institutional affiliations; he/she will be assisted by the board of directors: directors of the 3 scientific departments and the department of core facilities, directors of international and clinical affairs and the head of support services. The Inserm, CNRS and Université de Paris will provide an additional support to the director, in particular in terms of management.
Eligible individuals
with a permanent position at the CNRS, INSERM or Université de Paris, or, upon specific administrative agreement, at any other University or Research Establishment are welcome to apply. His/her mission will start any time from January 1 to June 30, 2022, around midway through the current 2019-2024 term contract of the Institute, and will be renewed for the next 5-year term contract. This will provide an opportunity for a transition period with the present director, Pierre-Olivier Couraud.
Applications
CV, achievements and a letter of motivation. They should be sent to [email protected] before May the 31st, 2021.
